Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shogo Ohkoshi

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Molecular and Clinical Oncology|December 2, 2015
Characteristics of colorectal tumours in asymptomatic patients with negative immunochemical faecal occult blood test resultsKunihiko Wakamura, Shin-Ei Kudo, Hideyuki Miyachi, et al.
Journal of Gastroenterology and Hepatology|August 9, 2007
Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNANaoya Sakamoto, Yoko Tanabe, Takanori Yokota, et al.
Hepato-Gastroenterology|March 2, 2006
Absence of pretreatment markers that predict the emergence of YMDD mutants during lamivudine treatment--the results of a prospective multi-center studyMasahiko Yano, Shogo Ohkoshi, Kenta Suzuki, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Molecular and Clinical Oncology|December 2, 2015
Characteristics of colorectal tumours in asymptomatic patients with negative immunochemical faecal occult blood test resultsKunihiko Wakamura, Shin-Ei Kudo, Hideyuki Miyachi, et al.
Journal of Gastroenterology and Hepatology|August 9, 2007
Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNANaoya Sakamoto, Yoko Tanabe, Takanori Yokota, et al.
Hepato-Gastroenterology|March 2, 2006
Absence of pretreatment markers that predict the emergence of YMDD mutants during lamivudine treatment--the results of a prospective multi-center studyMasahiko Yano, Shogo Ohkoshi, Kenta Suzuki, et al.
Pageof 5